Manufacturer record
Bonn Stering Bio Science LLP: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Bonn Stering Bio Science LLP (Puducherry) were declared Not of Standard Quality between July 2026 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BL-299, Ambroxol Hydrochloride, levosalbutamol sulphate and Guaiphenesin Syrup (exp Jan 2028). DTL, Chennai-06 (state lab) found it not of standard quality: Content - Ambroxol Hydrochloride. Listed in the August 2026 alert.
Records by type
2 records linked to Bonn Stering Bio Science LLP in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ambroxol Hydrochloride, levosalbutamol sulphate and Guaiphenesin Syrup | Batch BL-299Mfg Feb 2026 · Exp Jan 2028 | Content - Ambroxol HydrochlorideOther | DTL, Chennai-06State lab | Aug 2026 |
| Aceclofenac & Paracetamol Tablets | Batch BLPT-053Mfg Apr 2026 · Exp Mar 2028 | Content of Aceclofenac (81.98%) and Paracetamol (81.62%)Other | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.